IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 81 - 100 of 1134 stories.
May 8, 2014
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, reports a net loss of $6.37 million in the first quarter of 2014 compared...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Codexis-narrows-loss_60892.html
May 6, 2014
The oral solid-dosage form (OSDF) excipients market, which is valued at nearly $2.3 billion in the United States, Europe, India, and China, is growing sustainably on a global scale...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Study-Oral-solid-dosage-form-excipients-market-growing-at-7-4-percentyear_60818.html
May 6, 2014
Cambrex reports huge fall in profits Cambrex (East Rutherford, NJ) reports a 91.2% fall in net profits for the first quarter of 2014 compared with the year-ago period, to $982,000...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-May-2014_60821.html
May 2, 2014
Sun Pharma (Mumbai), India’s major pharmaceuticals player, said today that it is closing its Detroit manufacturing plant as part of a consolidation. The company has not said how...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sun-Pharma-to-close-Detroit-plant_60764.html
May 2, 2014
Cambrex (East Rutherford, NJ) reports a 91.2% fall in net profits for the first quarter of 2014 compared with the year-ago period, to $982,000. First-quarter sales decreased 11.2%, to...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-huge-fall-in-profits_60760.html
May 2, 2014
Pfizer announced today that it has submitted a revised written proposal to AstraZeneca to combine the two companies. The move follows consultation with major shareholders. Pfizer says...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-raises-offer-for-AstraZeneca-sends-letter-to-UK-prime-minister_60757.html
April 29, 2014
Demand growth boosts Lonza’s first-quarter performance Lonza, in its business update announcement for the first quarter of 2014, says that the year started with good momentum...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-29-April-2014_60649.html
April 24, 2014
SAFC Commercial, the custom-manufacturing and services business unit of Sigma-Aldrich, reports a 2.6% increase in sales in the first quarter of 2014 compared with the year-ago quarter...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-reports-slight-increase-in-first-quarter-sales_60519.html
April 22, 2014
UK press over the weekend said that Pfizer has made initial approaches to acquire AstraZeneca for £60 billion ($101 billion) in the world’s largest pharma acquisition. Both...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-eyes-AstraZeneca-for-a-reported-$100-billion_60445.html
April 22, 2014
SI Group to acquire Albemarle’s ibuprofen business SI Group (Schenectady, NY) has agreed to acquire the antioxidant, ibuprofen, and propofol businesses of Albemarle for an...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-22-April-2014_60456.html
April 16, 2014
SI Group (Schenectady, NY) has agreed to acquire the antioxidant, ibuprofen and propofol businesses of Albemarle for an undisclosed amount of cash. The deal includes manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SI-Group-to-acquire-Albemarles-antioxidants-and-ibuprofen-business_60349.html
April 16, 2014
Albemarle today reported net income down 32.6% year-on-year (YOY), to $56.6 million, or 71 cts/share, on net sales up 2.3%, to $656.7 million. Net income fell primarily due to charges...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-earnings-fall-but-beat-estimates_60350.html
April 15, 2014
Mitsubishi Chemical subsidiary and Neuland open pharma ingredients plant in India Neuland Laboratories (Hyderabad, India), a pharmaceutical manufacturer that provides active...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-15-April-2014_60298.html
April 8, 2014
Neuland Laboratories (Hyderabad, India) a pharmaceutical manufacturer that provides active pharmaceutical ingredients (APIs), complex intermediates, and contract manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Chemical-subsidiary-and-Neuland-open-pharma-ingredients-plant-in-India_60176.html
April 8, 2014
FDA issues warning letter to GlaxoSmithKline’s API plant in Ireland The US FDA issued a warning letter on 18 March to the active pharmaceutical ingredient (API) manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-8-April-2014_60169.html
April 7, 2014
Evonik has expanded its technical service laboratory for pharmaceutical polymers in Shanghai from 130 sq meters to 750 square meters in response to the dynamic growth of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Evonik-completes-expansion-of-service-lab-for-pharmaceutical-polymers-in-China_60142.html
April 7, 2014
Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has completed the previously announced acquisition of Cedarburg Hauser Pharmaceuticals (Grafton, WI). Total consideration...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-completes-acquisition-of-API-firm-Cedarburg_60133.html
April 2, 2014
The US FDA issued a warning letter on 18 March to the active pharmaceutical ingredient (API) manufacturing facility of GlaxoSmithKline (GSK; London) located at Carrigaline in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-GlaxoSmithKlines-API-plant-in-Ireland_60001.html
April 1, 2014
China to better supervise drug safety The Chinese government says it will establish a more rigorous supervision system this year, for food and drug safety. Harsh punishments would be...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-1-April-2014_59966.html
March 28, 2014
Asahi Kasei Chemicals (AKC), an Asahi Kasei subsidiary, on 27 March, officially opened its previously announced new acetonitrile plant at Ulsan, South Korea. The new, 11,000-m.t./year...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Asahi-Kasei-opens-acetonitrile-plant-in-South-Korea_59891.html
Pages: « Previous  1 2 3 4 [5] 6 7 8 9 10 11 12 13 14 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa